Karen E. Stevens

5.3k total citations
82 papers, 4.4k citations indexed

About

Karen E. Stevens is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Cognitive Neuroscience. According to data from OpenAlex, Karen E. Stevens has authored 82 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Molecular Biology, 58 papers in Cellular and Molecular Neuroscience and 18 papers in Cognitive Neuroscience. Recurrent topics in Karen E. Stevens's work include Neuroscience and Neuropharmacology Research (45 papers), Receptor Mechanisms and Signaling (44 papers) and Nicotinic Acetylcholine Receptors Study (44 papers). Karen E. Stevens is often cited by papers focused on Neuroscience and Neuropharmacology Research (45 papers), Receptor Mechanisms and Signaling (44 papers) and Nicotinic Acetylcholine Receptors Study (44 papers). Karen E. Stevens collaborates with scholars based in United States, Japan and Australia. Karen E. Stevens's co-authors include Robert Freedman, William R. Kem, Ann Olincy, Sherry Leonard, Lawrence E. Adler, Catherine E. Adams, Gregory M. Rose, Vladimir M. Mahnir, Johanna K. Simosky and Josette G. Harris and has published in prestigious journals such as Science, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Karen E. Stevens

82 papers receiving 4.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karen E. Stevens United States 34 2.7k 1.8k 1.0k 520 464 82 4.4k
Joseph G. Wettstein United States 36 2.3k 0.9× 2.7k 1.5× 1.5k 1.4× 397 0.8× 224 0.5× 91 5.3k
Michael S. Lidow United States 42 1.6k 0.6× 2.6k 1.5× 1.2k 1.1× 667 1.3× 201 0.4× 68 4.5k
John F. Neumaier United States 37 1.5k 0.6× 2.6k 1.5× 973 1.0× 388 0.7× 404 0.9× 102 4.4k
Lynette C. Daws United States 36 1.6k 0.6× 2.4k 1.4× 586 0.6× 333 0.6× 338 0.7× 106 4.1k
Roberto William Invernizzi Italy 42 1.5k 0.6× 3.0k 1.7× 768 0.8× 652 1.3× 806 1.7× 100 4.4k
Mirjana Carli Italy 40 1.4k 0.5× 2.9k 1.7× 1.7k 1.7× 607 1.2× 393 0.8× 67 4.5k
Patricia M. Whitaker‐Azmitia United States 35 1.4k 0.5× 2.1k 1.2× 936 0.9× 397 0.8× 327 0.7× 68 4.5k
Evelyn K. Lambe Canada 33 1.3k 0.5× 1.7k 1.0× 1.0k 1.0× 365 0.7× 198 0.4× 65 3.3k
Claudia Schmauss United States 38 2.3k 0.9× 2.4k 1.4× 511 0.5× 344 0.7× 233 0.5× 65 4.6k
Judith A. Pratt United Kingdom 32 1.1k 0.4× 1.8k 1.0× 870 0.9× 346 0.7× 417 0.9× 87 3.1k

Countries citing papers authored by Karen E. Stevens

Since Specialization
Citations

This map shows the geographic impact of Karen E. Stevens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen E. Stevens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen E. Stevens more than expected).

Fields of papers citing papers by Karen E. Stevens

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen E. Stevens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen E. Stevens. The network helps show where Karen E. Stevens may publish in the future.

Co-authorship network of co-authors of Karen E. Stevens

This figure shows the co-authorship network connecting the top 25 collaborators of Karen E. Stevens. A scholar is included among the top collaborators of Karen E. Stevens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen E. Stevens. Karen E. Stevens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Freund, Ronald K., Sharon Graw, Kevin S. Choo, et al.. (2016). Genetic knockout of the α7 nicotinic acetylcholine receptor gene alters hippocampal long-term potentiation in a background strain-dependent manner. Neuroscience Letters. 627. 1–6. 14 indexed citations
2.
Smucny, Jason, Karen E. Stevens, & Jason R. Tregellas. (2015). The antiepileptic drug levetiracetam improves auditory gating in DBA/2 mice. Schizophrenia. 1(1). 8 indexed citations
3.
Tregellas, Jason R., Jason Smucny, Kristina T. Legget, & Karen E. Stevens. (2015). Effects of a ketogenic diet on auditory gating in DBA/2 mice: A proof-of-concept study. Schizophrenia Research. 169(1-3). 351–354. 9 indexed citations
4.
Stevens, Karen E., Kevin S. Choo, Jerry A. Stitzel, Michael J. Marks, & Catherine E. Adams. (2014). Long-term improvements in sensory inhibition with gestational choline supplementation linked to α7 nicotinic receptors through studies in Chrna7 null mutation mice. Brain Research. 1552. 26–33. 23 indexed citations
5.
Stevens, Karen E., et al.. (2013). Intermittent versus continuous central administration of clozapine in DBA/2 mice, improvement in sensory inhibition deficits. Schizophrenia Research. 149(1-3). 121–126. 6 indexed citations
6.
7.
8.
Bates, Ryan, Bradley J. Stith, & Karen E. Stevens. (2012). Chronic central administration of valproic acid: Increased pro-survival phospho-proteins and growth cone associated proteins with no behavioral pathology. Pharmacology Biochemistry and Behavior. 103(2). 237–244. 3 indexed citations
9.
Zheng, Lijun, et al.. (2009). Ondansetron results in improved auditory gating in DBA/2 mice through a cholinergic mechanism. Brain Research. 1300. 41–50. 15 indexed citations
10.
Stevens, Karen E., et al.. (2008). Perinatal choline deficiency produces abnormal sensory inhibition in Sprague–Dawley rats. Brain Research. 1237. 84–90. 20 indexed citations
11.
Zheng, Lijun, Kevin S. Choo, Jun J. Yang, et al.. (2008). An initial animal proof-of-concept study for central administration of clozapine to schizophrenia patients. Schizophrenia Research. 100(1-3). 86–96. 9 indexed citations
12.
Stevens, Karen E., et al.. (2008). Stimulation of the α4β2 nicotinic receptor by 5-I A-85380 improves auditory gating in DBA/2 mice. Brain Research. 1224. 29–36. 24 indexed citations
13.
Olincy, Ann & Karen E. Stevens. (2007). Treating schizophrenia symptoms with an α7 nicotinic agonist, from mice to men. Biochemical Pharmacology. 74(8). 1192–1201. 109 indexed citations
14.
Olincy, Ann, Josette G. Harris, Lynn Johnson, et al.. (2006). Proof-of-Concept Trial of an α7 Nicotinic Agonist in Schizophrenia. Archives of General Psychiatry. 63(6). 630–630. 425 indexed citations
15.
O’Neill, Heidi C., et al.. (2003). Lithium alters measures of auditory gating in two strains of mice. Biological Psychiatry. 54(8). 847–853. 15 indexed citations
16.
Simosky, Johanna K., Karen E. Stevens, Lawrence E. Adler, & Robert Freedman. (2003). Clozapine improves deficient inhibitory auditory processing in DBA/2 mice, via a nicotinic cholinergic mechanism. Psychopharmacology. 165(4). 386–396. 108 indexed citations
17.
Stevens, Karen E., Amy Bullock, & Allan C. Collins. (2001). Chronic corticosterone treatment alters sensory gating in C3H mice. Pharmacology Biochemistry and Behavior. 69(3-4). 359–366. 35 indexed citations
18.
Miller, Christine L., Margit Burmeister, & Karen E. Stevens. (1999). Hippocampal auditory gating in the hyperactive mocha mouse. Neuroscience Letters. 276(1). 57–60. 14 indexed citations
19.
Stevens, Karen E., J. Meltzer, & Gregory M. Rose. (1993). Disruption of sensory gating by the α2 selective noradrenergic antagonist yohimbine. Biological Psychiatry. 33(2). 130–132. 46 indexed citations
20.
Stevens, Karen E., et al.. (1991). Dopaminergic and noradrenergic modulation of amphetamine-induced changes in auditory gating. Brain Research. 555(1). 91–98. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joseph G. Wettstein Breakdown of academic impact, for papers by Michael S. Lidow Breakdown of academic impact, for papers by John F. Neumaier Breakdown of academic impact, for papers by Lynette C. Daws Breakdown of academic impact, for papers by Roberto William Invernizzi Breakdown of academic impact, for papers by Mirjana Carli Breakdown of academic impact, for papers by Patricia M. Whitaker‐Azmitia Breakdown of academic impact, for papers by Evelyn K. Lambe Breakdown of academic impact, for papers by Claudia Schmauss Breakdown of academic impact, for papers by Judith A. Pratt
Rankless by CCL
2026